Table 1.
Population statistics of patients with newly diagnosed GBM
| Population statistics | Category | Absolute | Percentage |
|---|---|---|---|
| Median age at diagnosis | 61.0 | ||
| Average age at death | 60.5 | ||
| Gender | M | 44 | 60 % |
| F | 29 | 40 % | |
| Extent of resection | GTR | 38 | 52 % |
| STR | 24 | 33 % | |
| Biopsy | 11 | 15 % | |
| Median RT dose | 6000 | ||
| Concurrent agents | Temozolomide alone | 39 | 53 % |
| Temozolomide and Bevacizumab | 34 | 47 % | |
| Smoker | No | 43 | 60 % |
| Yes | 29 | 40 % | |
| HTN | No | 32 | 44 % |
| Yes | 41 | 56 % | |
| BMI | Normal (<25) | 17 | 23 % |
| Overweight (25–30) | 37 | 51 % | |
| Obese (>30) | 19 | 26 % | |
| DM | No | 63 | 86 % |
| Yes | 10 | 14 % | |
| Hyperlipidemia | No | 46 | 63 % |
| Yes | 27 | 37 % | |
| Dexamethasone during RT | No | 37 | 51 % |
| Yes | 36 | 49 % |